Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$3.3700
-0.1600 ( -3.16% ) 596.3K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$3.3700
Previous close
$3.5300
Volume
596.3K
Market cap
$227.77M
Day range
$3.3150 - $3.5280
52 week range
$2.7000 - $19.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 124 | Mar 28, 2024 |
8-k | 8K-related | 16 | Mar 28, 2024 |
8-k | 8K-related | 14 | Mar 25, 2024 |
8-k | 8K-related | 117 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
8-k | 8K-related | 103 | Mar 08, 2024 |
8-k | 8K-related | 22 | Mar 06, 2024 |
8-k | 8K-related | 104 | Feb 05, 2024 |
4 | Insider transactions | 1 | Feb 01, 2024 |
3 | Insider transactions | 1 | Feb 01, 2024 |